FDA approves Sunlenca for treatment-resistant HIV
The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other available ...
Dec 29, 2022
0
14